Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1023594-62-8

Post Buying Request

1023594-62-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1023594-62-8 Usage

Uses

tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate is used as a reactant in the preparation of heteroaryl amides as PIM kinase inhibitors for treating cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 1023594-62-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,3,5,9 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1023594-62:
(9*1)+(8*0)+(7*2)+(6*3)+(5*5)+(4*9)+(3*4)+(2*6)+(1*2)=128
128 % 10 = 8
So 1023594-62-8 is a valid CAS Registry Number.

1023594-62-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl (1-(2-nitrophenyl)piperidin-4-yl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl N-[1-(2-nitrophenyl)piperidin-4-yl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1023594-62-8 SDS

1023594-62-8Upstream product

1023594-62-8Downstream Products

1023594-62-8Relevant articles and documents

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

-

Page/Page column 46, (2008/12/07)

New compounds, compositions and methods of inhibition of kinase activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one serine/threonine kinase or receptor tyrosine kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase- mediated disorder, such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1023594-62-8